+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Histology & Cytology Market Research Report by Type of Examination, Product, End-user, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 126 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5455785
UP TO OFF until Dec 31st 2022
The United States Histology & Cytology Market size was estimated at USD 3,264.46 million in 2021, USD 3,911.77 million in 2022, and is projected to grow at a CAGR of 16.07% to reach USD 7,986.01 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Histology & Cytology to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type of Examination, the market was studied across Cytology and Histology. The Cytology is further studied across Breast Cancer and Cervical Cancer.
  • Based on Product, the market was studied across Consumable and Reagents and Instruments and Analysis Software System.
  • Based on End-user, the market was studied across Clinical Diagnostics and Life Sciences.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Histology & Cytology market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Histology & Cytology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Histology & Cytology Market, including Abbott Laboratories Inc., Agilent Technologies, Inc., Becton, Dickinson & Company, CellPath Ltd, Danaher Corporation, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hologic, Inc., Koninklijke Philips N.V., Medimeas, Merck KGaA, Novartis AG, PerkinElmer Inc., Polysciences, Inc., Southwest Precision Instruments, LLC, Syntec Scientific Corporation, Sysmex Corporation, Thermo Fisher Scientific, Inc., and Trivitron Healthcare.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Histology & Cytology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Histology & Cytology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Histology & Cytology Market?
4. What is the competitive strategic window for opportunities in the United States Histology & Cytology Market?
5. What are the technology trends and regulatory frameworks in the United States Histology & Cytology Market?
6. What is the market share of the leading vendors in the United States Histology & Cytology Market?
7. What modes and strategic moves are considered suitable for entering the United States Histology & Cytology Market?
Frequently Asked Questions about the U.S. Histology & Cytology Market

What is the estimated value of the U.S. Histology & Cytology Market?

The U.S. Histology & Cytology Market was estimated to be valued at $3264.46 Million in 2021.

What is the growth rate of the U.S. Histology & Cytology Market?

The growth rate of the U.S. Histology & Cytology Market is 16.0%, with an estimated value of $7986.01 Million by 2027.

What is the forecasted size of the U.S. Histology & Cytology Market?

The U.S. Histology & Cytology Market is estimated to be worth $7986.01 Million by 2027.

Who are the key companies in the U.S. Histology & Cytology Market?

Key companies in the U.S. Histology & Cytology Market include Abbott Laboratories Inc., Agilent Technologies, Inc., Becton, Dickinson & Company, CellPath Ltd, Danaher Corporation, Eli Lilly and Company, F. Hoffmann, La Roche Ltd. and Hologic, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Histology & Cytology Market, by Type of Examination
6.1. Introduction
6.2. Cytology
6.3.1. Breast Cancer
6.3.2. Cervical Cancer
6.3. Histology
7. Histology & Cytology Market, by Product
7.1. Introduction
7.2. Consumable and Reagents
7.3. Instruments and Analysis Software System
8. Histology & Cytology Market, by End-user
8.1. Introduction
8.2. Clinical Diagnostics
8.3. Life Sciences
9. California Histology & Cytology Market
9.1. Introduction
10. Florida Histology & Cytology Market
10.1. Introduction
11. Illinois Histology & Cytology Market
11.1. Introduction
12. New York Histology & Cytology Market
12.1. Introduction
13. Ohio Histology & Cytology Market
13.1. Introduction
14. Pennsylvania Histology & Cytology Market
14.1. Introduction
15. Texas Histology & Cytology Market
15.1. Introduction
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Abbott Laboratories Inc.
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Agilent Technologies, Inc.
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. Becton, Dickinson & Company
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. CellPath Ltd
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. Danaher Corporation
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Eli Lilly and Company
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. F. Hoffmann-La Roche Ltd.
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. GlaxoSmithKline PLC
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. Hologic, Inc.
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. Koninklijke Philips N.V.
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. Medimeas
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. Merck KGaA
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Novartis AG
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. PerkinElmer Inc.
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Polysciences, Inc.
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
17.16. Southwest Precision Instruments, LLC
17.16.1. Business Overview
17.16.2. Key Executives
17.16.3. Product & Services
17.17. Syntec Scientific Corporation
17.17.1. Business Overview
17.17.2. Key Executives
17.17.3. Product & Services
17.18. Sysmex Corporation
17.18.1. Business Overview
17.18.2. Key Executives
17.18.3. Product & Services
17.19. Thermo Fisher Scientific, Inc.
17.19.1. Business Overview
17.19.2. Key Executives
17.19.3. Product & Services
17.20. Trivitron Healthcare
17.20.1. Business Overview
17.20.2. Key Executives
17.20.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES HISTOLOGY & CYTOLOGY MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES HISTOLOGY & CYTOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES HISTOLOGY & CYTOLOGY MARKET DYNAMICS
FIGURE 8. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES HISTOLOGY & CYTOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE OF EXAMINATION, 2027
FIGURE 11. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY BREAST CANCER, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CERVICAL CANCER, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY HISTOLOGY, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES HISTOLOGY & CYTOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 18. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CONSUMABLE AND REAGENTS, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY INSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 21. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES HISTOLOGY & CYTOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 23. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2027 (USD MILLION)
FIGURE 25. CALIFORNIA HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 26. FLORIDA HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 27. ILLINOIS HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 28. NEW YORK HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 29. OHIO HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. PENNSYLVANIA HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. TEXAS HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. UNITED STATES HISTOLOGY & CYTOLOGY MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 33. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 34. UNITED STATES HISTOLOGY & CYTOLOGY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY BREAST CANCER, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY BREAST CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CERVICAL CANCER, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CERVICAL CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY HISTOLOGY, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY HISTOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CONSUMABLE AND REAGENTS, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CONSUMABLE AND REAGENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY INSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY INSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY LIFE SCIENCES, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY LIFE SCIENCES, BY STATE, 2018-2027 (USD MILLION)
TABLE 24. CALIFORNIA HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. CALIFORNIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2027 (USD MILLION)
TABLE 26. CALIFORNIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 27. CALIFORNIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 28. FLORIDA HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. FLORIDA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2027 (USD MILLION)
TABLE 30. FLORIDA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 31. FLORIDA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 32. ILLINOIS HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. ILLINOIS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2027 (USD MILLION)
TABLE 34. ILLINOIS HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 35. ILLINOIS HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 36. NEW YORK HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. NEW YORK HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2027 (USD MILLION)
TABLE 38. NEW YORK HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 39. NEW YORK HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 40. OHIO HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. OHIO HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2027 (USD MILLION)
TABLE 42. OHIO HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 43. OHIO HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 44. PENNSYLVANIA HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. PENNSYLVANIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2027 (USD MILLION)
TABLE 46. PENNSYLVANIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 47. PENNSYLVANIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 48. TEXAS HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. TEXAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2027 (USD MILLION)
TABLE 50. TEXAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 51. TEXAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 52. UNITED STATES HISTOLOGY & CYTOLOGY MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 53. UNITED STATES HISTOLOGY & CYTOLOGY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 54. UNITED STATES HISTOLOGY & CYTOLOGY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 55. UNITED STATES HISTOLOGY & CYTOLOGY MARKET RANKING, BY KEY PLAYER, 2021
TABLE 56. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SHARE, BY KEY PLAYER, 2021
TABLE 57. UNITED STATES HISTOLOGY & CYTOLOGY MARKET MERGER & ACQUISITION
TABLE 58. UNITED STATES HISTOLOGY & CYTOLOGY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 59. UNITED STATES HISTOLOGY & CYTOLOGY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 60. UNITED STATES HISTOLOGY & CYTOLOGY MARKET INVESTMENT & FUNDING
TABLE 61. UNITED STATES HISTOLOGY & CYTOLOGY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 62. UNITED STATES HISTOLOGY & CYTOLOGY MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • CellPath Ltd
  • Danaher Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Medimeas
  • Merck KGaA
  • Novartis AG
  • PerkinElmer Inc.
  • Polysciences, Inc.
  • Southwest Precision Instruments, LLC
  • Syntec Scientific Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare

Methodology

Loading
LOADING...